Nephron Works to Resolve Nationwide Drug Shortage by Producing Vital Medications

08 Aug 2023
WEST COLUMBIA, S.C., Aug. 8, 2023 /PRNewswire/
-- Nephron 503B Outsourcing Facility, a division of Nephron Pharmaceuticals Corporation, is focused on resolving drug shortage concerns with the production of 0.5% Albuterol 5 mL, del Nido Cardioplegia, Lidocaine 1% and Succinylcholine products.
The following medications are readily available for order through the Nephron online ordering portal:
Continue Reading
Nephron Works to Resolve Nationwide Drug Shortage by Producing Vital Medications
Preview
Source: PRNewswire
Nephron 503B Outsourcing Facility, a division of Nephron Pharmaceuticals Corporation, is focused on resolving drug shortage concerns with the production of 0.5% Albuterol 5 mL, del Nido Cardioplegia, Lidocaine 1% and Succinylcholine products.
0.5% Albuterol 25 mg/5 mL (5 mg/mL) Preservative Free
del Nido Cardioplegia Solution 1000 mL
Lidocaine Injection Vial, USP 1% 50 mg/5 mL (10 mg/mL) Preservative Free
Succinylcholine Chloride Injection, USP 200 mg/10 mL (20 mg/mL) Preservative Free
"As a nationwide leader in manufacturing lifesaving medication, we work hard every single day to help the federal government alleviate drug shortages - and to deliver hospitals and patients the treatments they deserve and expect in a timely manner," said Lou Kennedy, CEO and Owner of Nephron. "Playing this vital role in manufacturing is all the motivation we need to do our jobs well - and stay focused on precisely what it takes to raise the bar not only for our team, but for manufacturers everywhere."
Nephron has over 25 years of sterile pharmaceutical manufacturing experience and operates an industry-leading 503B Outsourcing Facility division which produces pre-filled sterile syringes, luer-lock vials, IV bottles and IV bags for hospitals across America.
To place an order, customers can contact Nephron directly at [email protected] or 1-844-224-2225.
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
-
Targets
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.